Examining a role for irisin in treating cerebral ischemia

Area of Science:

• Neuroscience
• Endocrinology
• Exercise Physiology

Background:

• Stroke, particularly ischemic stroke, is a major cause of death and disability, with aging populations increasing the need for effective interventions.
• Physical inactivity is a significant stroke risk factor, highlighting the importance of exercise for recovery and prevention.
• Irisin, a myokine released during exercise from the FNDC5 gene product, is being investigated for its role in neurological health.

Purpose of the Study:

• To review the current literature on irisin's multifaceted role in ischemic stroke.
• To examine irisin's effects on stroke risk, prognosis, and functional outcomes.
• To explore the potential of exogenous irisin administration as a therapeutic strategy.

Main Methods:

• Literature review of studies investigating irisin in the context of ischemic stroke.
• Analysis of irisin's association with stroke risk, patient outcomes, and mortality.
• Examination of preclinical data on the neuroprotective effects of exogenous irisin.

Main Results:

• Low irisin levels are correlated with poorer outcomes and increased mortality in ischemic stroke patients, suggesting its prognostic value.
• High-intensity resistance training significantly elevates irisin levels, potentially mediating exercise benefits.
• Exogenous irisin demonstrated neuroprotective effects in murine models, reducing brain damage and enhancing recovery markers.

Conclusions:

• Irisin serves as a potential prognostic biomarker for ischemic stroke.
• Exercise, especially resistance training, may improve stroke outcomes partly through irisin.
• Further human trials are essential to validate irisin's therapeutic potential for acute stroke care.